| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 33 |
| 1 | PREDNISOLONE ORAL | 33 |
| 2 | PREDNISOLONE ORAL SOLUTION | 33 |
| 3 | PREDNISONE | 32 |
| 4 | METHOTREXATE SODIUM | 30 |
| 5 | PACLITAXEL | 30 |
| 6 | METHOTREXATE | 28 |
| 7 | CYCLOPHOSPHAMIDE | 27 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 27 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 1 | DINUTUXIMAB | 3 | 0.0035 |
| 2 | QUIZARTINIB | 2 | 0.0028 |
| 3 | GOLIMUMAB | 22 | 0.0017 |
| 4 | PIOGLITAZONE HYDROCHLORIDE | 2 | 0.0016 |
| 5 | ACYCLOVIR SODIUM | 2 | 0.0016 |
| 6 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 7 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 8 | PEGFILGRASTIM | 11 | 0.0009 |
| 9 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 83 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 60 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 56 |
| 3 | Alkylating Drug [EPC] | 30 |
| 4 | Microtubule Inhibitor [EPC] | 30 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| 6 | Proton Pump Inhibitor [EPC] | 28 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 23 |
| 8 | Platinum-based Drug [EPC] | 21 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 3 | Bismuth [EPC] | 2 | 0.0004 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 6 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 7 | Microtubule Inhibitor [EPC] | 30 | 0.0002 |
| 8 | Interleukin-23 Antagonist [EPC] | 17 | 0.0002 |
| 9 | Interleukin-12 Antagonist [EPC] | 14 | 0.0001 |